Experimental Treatment of Mucinous Peritoneal Metastases Using Patient-Derived Xenograft Models

Mucinous peritoneal metastases (PM) generally respond poorly to systemic treatment, and there is a clear unmet need for new treatment strategies to improve survival and quality of life for patients with PM. In this work, the growth inhibitory effect of five drugs (oxaliplatin (OXA; 5 mg/kg), irinote...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleten, Karianne Giller, Lund-Andersen, Christin, Waagene, Stein, Abrahamsen, Torveig Weum, Mørch, Yrr, Boye, Kjetil, Torgunrud, Annette, Flatmark, Kjersti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243185/
https://www.ncbi.nlm.nih.gov/pubmed/32447231
http://dx.doi.org/10.1016/j.tranon.2020.100793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243185/
https://www.ncbi.nlm.nih.gov/pubmed/32447231
http://dx.doi.org/10.1016/j.tranon.2020.100793

Ejemplares similares